Clinical trial of a new antibiotic.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000667:Ampicillin / Q000494:pharmacology; D001219:Aspartate Aminotransferases / Q000097:blood; D002648:Child; D002986:Clinical Trials as Topic; D004064:Digestive System / Q000187:drug effects; D004917:Erythromycin / Q000494:pharmacology; D005260:Female; D006192:Haemophilus Infections / Q000188:drug therapy; D006193:Haemophilus influenzae / Q000187:drug effects; D006801:Humans; D008034:Lincomycin / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008297:Male; D008712:Methicillin / Q000494:pharmacology; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010019:Osteomyelitis / Q000188:drug therapy; D010403:Penicillin Resistance; D010406:Penicillins / Q000494:pharmacology; D012141:Respiratory Tract Infections / Q000188:drug therapy; D018805:Sepsis / Q000188:drug therapy; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013291:Streptococcus / Q000187:drug effects; D013297:Streptococcus pyogenes / Q000187:drug effects; D013752:Tetracycline / Q000494:pharmacology; D013997:Time Factors
D010406:Penicillins; D004917:Erythromycin; D000667:Ampicillin; D008034:Lincomycin; D001219:Aspartate Aminotransferases; D013752:Tetracycline; D008712:Methicillin